Star Combo Pharma

Star Combo Pharma EBITDA per Share

EBITDA per Share of Star Combo Pharma (S66.AX) as of Nov 12, 2026.

EBITDA per Share

-0.00AUD

YoY

-2.89%

Last updated:

EBITDA per Share of Star Combo Pharma is 2026 -0.00 AUD. EBITDA per Share of Star Combo Pharma was 2025 -0.00 AUD. It decreases by -2.89% higher compared to the previous year.

The Star Combo Pharma EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-0.03 AUD
Jan 1, 2020
-0.00 AUD
Jan 1, 2021
-0.05 AUD
Jan 1, 2022
-0.00 AUD
Jan 1, 2023
0.01 AUD
Jan 1, 2024
0.01 AUD
Jan 1, 2025
-0.00 AUD
Jan 1, 2026
-0.00 AUD
The Star Combo Pharma EBITDA per Share history
YEAREBITDA per ShareYoY
-0.00AUD-2.89%
-0.00AUD-133.65%
0.01AUD-26.46%
0.01AUD-315.84%
-0.00AUD-93.86%
-0.05AUD+1,312.34%
-0.00AUD-85.75%
-0.03AUD-14.33%
-0.03AUD-172.30%
0.04AUD+73.11%
0.02AUD+865.40%
0.00AUD-41.04%
0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Star Combo Pharma Stock analysis

What does Star Combo Pharma do? Star Combo Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Star Combo Pharma stock

On Eulerpool you can find the complete historical development of EBITDA per Share Star Combo Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Star Combo Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Star Combo Pharma